Skip to main content

Corcept Therapeutics

Corcept Therapeutics Inc is an American commercial-stage pharmaceutical enterprise headquartered in Menlo Park, California. The company focuses on the discovery, development, and commercialization of innovative medications that treat severe endocrine, oncological, and metabolic disorders by modulating cortisol activity through receptor antagonism. Its clinical portfolio is anchored by proprietary selective cortisol modulators. Principal revenue is derived through commercial sales of its flagship pharmaceutical products to healthcare providers and specialty pharmacies. Corcept Therapeutics Inc is publicly listed on the Nasdaq Stock Market.

4 of the funds FundTelligence covers report a position in Corcept Therapeutics.

Legal name
Corcept Therapeutics Inc
Sector
Health Care
Country
United States
Funds holding it
4
Exposure themes
Cancer, Treatment, Women's Health

Funds holding Corcept Therapeutics

Loading...